Cairo Pharmaceutical & Chemical Industries (CAI:CPCI) EV-to-Revenue : (As of Jun. 08, 2024)

View and export this data going back to 1996. Start your Free Trial

What is Cairo Pharmaceutical & Chemical Industries EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Cairo Pharmaceutical & Chemical Industries's enterprise value is E£565.71 Mil. Cairo Pharmaceutical & Chemical Industries does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Cairo Pharmaceutical & Chemical Industries's EV-to-Revenue at this moment.

The historical rank and industry rank for Cairo Pharmaceutical & Chemical Industries's EV-to-Revenue or its related term are showing as below:

CAI:CPCI's EV-to-Revenue is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.275
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-08), Cairo Pharmaceutical & Chemical Industries's stock price is E£66.08. Cairo Pharmaceutical & Chemical Industries does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Cairo Pharmaceutical & Chemical Industries's PS Ratio at this moment.

Cairo Pharmaceutical & Chemical Industries EV-to-Revenue Historical Data

The historical data trend for Cairo Pharmaceutical & Chemical Industries's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cairo Pharmaceutical & Chemical Industries EV-to-Revenue Chart

Cairo Pharmaceutical & Chemical Industries Annual Data

Trend

EV-to-Revenue

Cairo Pharmaceutical & Chemical Industries Quarterly Data

EV-to-Revenue

Competitive Comparison of Cairo Pharmaceutical & Chemical Industries's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Cairo Pharmaceutical & Chemical Industries's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cairo Pharmaceutical & Chemical Industries's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cairo Pharmaceutical & Chemical Industries's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cairo Pharmaceutical & Chemical Industries's EV-to-Revenue falls into.

Cairo Pharmaceutical & Chemical Industries EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Cairo Pharmaceutical & Chemical Industries's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	565.714	/
	=

Cairo Pharmaceutical & Chemical Industries (CAI:CPCI) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Cairo Pharmaceutical & Chemical Industries's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	66.08	/
	=

Cairo Pharmaceutical & Chemical Industries EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cairo Pharmaceutical & Chemical Industries's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cairo Pharmaceutical & Chemical Industries (CAI:CPCI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cairo Pharmaceutical & Chemical Industries SA (CAI:CPCI) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Abdelhamid El-Dib Street, Victoria Square, Shubra, Cairo, EGY

Website

http://www.kahira-pharma.com

Cairo Pharmaceutical & Chemical Industries SA manufactures & markets pharmaceutical products. It offers soft gelatin capsules, eye drops, film & sugar coated tablets, natural product and cosmetics, among other natural products.

Cairo Pharmaceutical & Chemical Industries (CAI:CPCI) Headlines

No Headlines